Traws Pharma, Inc. · NASDAQ:TRAW
Perceptive Advisors LLC reported a 9.90% stake in Traws Pharma, Inc. (Schedule 13G)
Event Dec 31, 2024 · Filed Jan 8, 2025
Perceptive Advisors LLC reported a 9.90% stake in Traws Pharma, Inc., 386,555 shares, as a passive investor on Dec 31, 2024. Filed Jan 8, 2025 (Schedule 13G).
- Stake
- 9.90%
- Shares
- 386,555
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Perceptive Advisors LLC | 9.90% | 386,555 |
| Joseph Edelman | 9.90% | 386,555 |
| Perceptive Life Sciences Master Fund, Ltd | 9.90% | 386,555 |
Source
Related
- Traws Pharma, Inc.
- Perceptive Advisors LLC
- Traws Pharma, Inc. shareholders
- Schedule 13G/A · Perceptive Advisors LLC · May 15, 2026
- Schedule 13G/A · Perceptive Advisors LLC · Nov 14, 2025
- Schedule 13G/A · Perceptive Advisors LLC · May 15, 2025
- Schedule 13G · Sirenia Capital Management LP · Aug 14, 2026
- Schedule 13G/A · Squadron Capital Management LLC · Aug 14, 2026
- Schedule 13G/A · Ikarian Capital, LLC · Aug 14, 2026
- Schedule 13G/A · Adage Capital Management, L.P. · Aug 12, 2026
- Schedule 13G/A · Squadron Capital Management LLC · May 15, 2026